Nancy Krebs
Concepts (748)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zinc | 113 | 2026 | 310 | 15.160 |
Why?
| | Infant Nutritional Physiological Phenomena | 44 | 2026 | 159 | 9.200 |
Why?
| | Dietary Supplements | 61 | 2026 | 587 | 7.870 |
Why?
| | Nutritional Status | 47 | 2026 | 346 | 6.520 |
Why?
| | Micronutrients | 30 | 2026 | 102 | 5.660 |
Why?
| | Maternal Nutritional Physiological Phenomena | 19 | 2026 | 178 | 5.570 |
Why?
| | Developing Countries | 78 | 2026 | 312 | 5.430 |
Why?
| | Diet | 66 | 2026 | 1273 | 5.410 |
Why?
| | Milk, Human | 34 | 2026 | 176 | 5.200 |
Why?
| | Breast Feeding | 48 | 2026 | 447 | 5.030 |
Why?
| | Infant Food | 26 | 2026 | 69 | 4.140 |
Why?
| | Intestinal Absorption | 38 | 2026 | 103 | 3.790 |
Why?
| | Meat | 13 | 2021 | 62 | 3.790 |
Why?
| | Child Development | 23 | 2026 | 481 | 3.580 |
Why?
| | Premature Birth | 26 | 2026 | 390 | 3.440 |
Why?
| | Infant | 163 | 2026 | 10114 | 3.420 |
Why?
| | Iron | 22 | 2026 | 359 | 3.070 |
Why?
| | Infant, Newborn | 128 | 2026 | 6460 | 3.000 |
Why?
| | Nutritional Requirements | 25 | 2019 | 78 | 2.990 |
Why?
| | Preconception Care | 12 | 2026 | 50 | 2.950 |
Why?
| | Pregnancy Outcome | 32 | 2025 | 503 | 2.940 |
Why?
| | Infant Mortality | 37 | 2026 | 127 | 2.930 |
Why?
| | Pregnancy | 143 | 2026 | 7230 | 2.890 |
Why?
| | Food, Fortified | 22 | 2026 | 43 | 2.870 |
Why?
| | Phytic Acid | 19 | 2017 | 35 | 2.630 |
Why?
| | Growth Disorders | 13 | 2026 | 89 | 2.460 |
Why?
| | Anemia, Iron-Deficiency | 11 | 2025 | 61 | 2.450 |
Why?
| | Infant Formula | 12 | 2026 | 71 | 2.300 |
Why?
| | Iron, Dietary | 9 | 2019 | 23 | 2.300 |
Why?
| | Guatemala | 40 | 2026 | 349 | 2.290 |
Why?
| | Prenatal Care | 24 | 2026 | 310 | 2.210 |
Why?
| | Perinatal Death | 13 | 2023 | 26 | 2.170 |
Why?
| | Stillbirth | 26 | 2026 | 83 | 2.160 |
Why?
| | Child Health | 20 | 2023 | 153 | 2.150 |
Why?
| | Female | 281 | 2026 | 79499 | 2.080 |
Why?
| | Azithromycin | 11 | 2026 | 101 | 1.980 |
Why?
| | Fetal Development | 8 | 2026 | 297 | 1.980 |
Why?
| | Humans | 359 | 2026 | 146342 | 1.960 |
Why?
| | Poverty | 13 | 2023 | 530 | 1.900 |
Why?
| | Lactation | 16 | 2025 | 193 | 1.870 |
Why?
| | Obesity, Morbid | 7 | 2021 | 287 | 1.800 |
Why?
| | Dietary Proteins | 12 | 2026 | 135 | 1.790 |
Why?
| | Pregnancy Complications, Infectious | 12 | 2026 | 438 | 1.790 |
Why?
| | Dairy Products | 3 | 2021 | 30 | 1.740 |
Why?
| | Energy Intake | 15 | 2026 | 507 | 1.740 |
Why?
| | Pakistan | 33 | 2026 | 83 | 1.720 |
Why?
| | Feces | 28 | 2026 | 496 | 1.700 |
Why?
| | Infant Health | 10 | 2023 | 24 | 1.700 |
Why?
| | Homeostasis | 21 | 2015 | 646 | 1.690 |
Why?
| | Obesity | 24 | 2024 | 3131 | 1.680 |
Why?
| | Cesarean Section | 8 | 2021 | 230 | 1.670 |
Why?
| | Body Mass Index | 23 | 2023 | 2458 | 1.590 |
Why?
| | Gastric Bypass | 6 | 2019 | 115 | 1.590 |
Why?
| | Delivery, Obstetric | 20 | 2026 | 164 | 1.560 |
Why?
| | Trace Elements | 13 | 2022 | 52 | 1.540 |
Why?
| | Infant, Small for Gestational Age | 8 | 2026 | 118 | 1.510 |
Why?
| | Mothers | 13 | 2024 | 772 | 1.450 |
Why?
| | Pregnancy Complications | 17 | 2025 | 609 | 1.440 |
Why?
| | Birth Weight | 23 | 2025 | 521 | 1.420 |
Why?
| | Maternal Mortality | 18 | 2025 | 52 | 1.380 |
Why?
| | Gastrointestinal Microbiome | 10 | 2025 | 769 | 1.350 |
Why?
| | Anemia | 10 | 2026 | 190 | 1.320 |
Why?
| | Malnutrition | 6 | 2026 | 87 | 1.300 |
Why?
| | Growth | 7 | 2020 | 48 | 1.230 |
Why?
| | Adult | 123 | 2026 | 41087 | 1.220 |
Why?
| | Maternal Health | 6 | 2023 | 50 | 1.190 |
Why?
| | Zea mays | 12 | 2017 | 45 | 1.160 |
Why?
| | Nutrition Assessment | 5 | 2025 | 90 | 1.160 |
Why?
| | Gestational Age | 17 | 2026 | 990 | 1.150 |
Why?
| | Anthropometry | 13 | 2024 | 204 | 1.150 |
Why?
| | Infant, Premature | 9 | 2023 | 622 | 1.120 |
Why?
| | Infant, Low Birth Weight | 15 | 2026 | 154 | 1.110 |
Why?
| | Child, Preschool | 55 | 2026 | 11913 | 1.110 |
Why?
| | India | 22 | 2026 | 213 | 1.100 |
Why?
| | Child | 71 | 2024 | 22693 | 1.100 |
Why?
| | Zinc Isotopes | 22 | 2011 | 22 | 1.090 |
Why?
| | Child Nutritional Physiological Phenomena | 9 | 2019 | 102 | 1.080 |
Why?
| | Weaning | 7 | 2026 | 50 | 1.080 |
Why?
| | Gastrectomy | 3 | 2021 | 164 | 1.030 |
Why?
| | Anti-Bacterial Agents | 10 | 2026 | 1942 | 1.020 |
Why?
| | Pre-Eclampsia | 5 | 2023 | 206 | 1.000 |
Why?
| | Feeding Behavior | 12 | 2023 | 692 | 1.000 |
Why?
| | Prospective Studies | 51 | 2026 | 8123 | 0.990 |
Why?
| | Zambia | 19 | 2026 | 61 | 0.980 |
Why?
| | Biological Availability | 22 | 2022 | 146 | 0.970 |
Why?
| | Rural Population | 18 | 2022 | 677 | 0.970 |
Why?
| | Nutritional Sciences | 5 | 2019 | 35 | 0.960 |
Why?
| | Biomarkers | 23 | 2026 | 4340 | 0.960 |
Why?
| | Body Composition | 10 | 2025 | 689 | 0.950 |
Why?
| | Democratic Republic of the Congo | 16 | 2026 | 33 | 0.930 |
Why?
| | Food | 3 | 2020 | 149 | 0.930 |
Why?
| | Male | 126 | 2026 | 73396 | 0.930 |
Why?
| | Registries | 28 | 2026 | 2400 | 0.920 |
Why?
| | Young Adult | 59 | 2026 | 14330 | 0.910 |
Why?
| | Double-Blind Method | 23 | 2026 | 2070 | 0.900 |
Why?
| | Vitamins | 4 | 2025 | 183 | 0.880 |
Why?
| | Perinatal Mortality | 11 | 2026 | 23 | 0.880 |
Why?
| | Weight Gain | 10 | 2026 | 562 | 0.840 |
Why?
| | Birth Intervals | 2 | 2021 | 23 | 0.830 |
Why?
| | Postpartum Period | 7 | 2026 | 377 | 0.830 |
Why?
| | Vaginal Birth after Cesarean | 2 | 2021 | 27 | 0.820 |
Why?
| | Powders | 10 | 2025 | 45 | 0.800 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 108 | 0.770 |
Why?
| | Premenopause | 3 | 2021 | 130 | 0.760 |
Why?
| | Anastomosis, Roux-en-Y | 2 | 2021 | 23 | 0.750 |
Why?
| | Maternal Health Services | 6 | 2019 | 100 | 0.750 |
Why?
| | Aspirin | 8 | 2026 | 405 | 0.740 |
Why?
| | Women's Health | 13 | 2023 | 317 | 0.740 |
Why?
| | Education, Medical | 4 | 2019 | 274 | 0.740 |
Why?
| | Hemoglobins | 8 | 2025 | 384 | 0.730 |
Why?
| | Sodium Chloride, Dietary | 4 | 2026 | 31 | 0.720 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2021 | 39 | 0.720 |
Why?
| | Antibiotic Prophylaxis | 5 | 2026 | 140 | 0.720 |
Why?
| | Nutritive Value | 4 | 2026 | 41 | 0.720 |
Why?
| | Vegetables | 2 | 2022 | 159 | 0.710 |
Why?
| | Obstetric Labor Complications | 6 | 2020 | 38 | 0.710 |
Why?
| | Inflammation | 7 | 2026 | 2919 | 0.710 |
Why?
| | Overweight | 7 | 2023 | 614 | 0.690 |
Why?
| | Edible Grain | 7 | 2014 | 45 | 0.690 |
Why?
| | Cesarean Section, Repeat | 1 | 2021 | 11 | 0.680 |
Why?
| | Bangladesh | 10 | 2026 | 64 | 0.680 |
Why?
| | Sepsis | 5 | 2026 | 669 | 0.660 |
Why?
| | Weight Reduction Programs | 2 | 2013 | 140 | 0.660 |
Why?
| | Body Height | 6 | 2022 | 205 | 0.660 |
Why?
| | Models, Biological | 9 | 2016 | 1761 | 0.640 |
Why?
| | Deficiency Diseases | 6 | 2019 | 10 | 0.630 |
Why?
| | Recommended Dietary Allowances | 3 | 2018 | 16 | 0.610 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 14 | 0.610 |
Why?
| | Milk Banks | 1 | 2019 | 1 | 0.610 |
Why?
| | Ultrasonography, Prenatal | 6 | 2020 | 291 | 0.600 |
Why?
| | Health Education | 4 | 2018 | 346 | 0.600 |
Why?
| | Longitudinal Studies | 21 | 2026 | 3017 | 0.600 |
Why?
| | Adolescent | 48 | 2025 | 22557 | 0.600 |
Why?
| | Malabsorption Syndromes | 1 | 2019 | 14 | 0.590 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2019 | 9 | 0.580 |
Why?
| | Dietary Fats | 2 | 2020 | 307 | 0.580 |
Why?
| | Kenya | 12 | 2026 | 129 | 0.580 |
Why?
| | Iron Metabolism Disorders | 2 | 2015 | 6 | 0.580 |
Why?
| | Maternal Death | 4 | 2020 | 13 | 0.570 |
Why?
| | Developed Countries | 2 | 2015 | 38 | 0.570 |
Why?
| | Organic Chemicals | 1 | 2020 | 113 | 0.560 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 349 | 0.550 |
Why?
| | Prevalence | 15 | 2026 | 2861 | 0.550 |
Why?
| | Avitaminosis | 1 | 2018 | 6 | 0.550 |
Why?
| | Nutrition Therapy | 2 | 2019 | 37 | 0.540 |
Why?
| | Parity | 8 | 2023 | 113 | 0.540 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 507 | 0.540 |
Why?
| | Malaria | 1 | 2019 | 73 | 0.540 |
Why?
| | Metabolomics | 2 | 2021 | 738 | 0.530 |
Why?
| | Enteritis | 1 | 2019 | 105 | 0.530 |
Why?
| | Body Size | 6 | 2019 | 91 | 0.530 |
Why?
| | Body Weight | 13 | 2019 | 968 | 0.510 |
Why?
| | Diarrhea | 5 | 2022 | 190 | 0.500 |
Why?
| | Weight Loss | 2 | 2013 | 858 | 0.490 |
Why?
| | Insulin | 7 | 2021 | 2525 | 0.490 |
Why?
| | Metabolome | 1 | 2020 | 390 | 0.470 |
Why?
| | Cross-Sectional Studies | 27 | 2026 | 5899 | 0.470 |
Why?
| | Leptin | 5 | 2018 | 248 | 0.470 |
Why?
| | Vitamin E | 1 | 2016 | 123 | 0.470 |
Why?
| | Global Health | 10 | 2025 | 403 | 0.460 |
Why?
| | Child Nutrition Sciences | 1 | 2015 | 7 | 0.460 |
Why?
| | Gastrointestinal Absorption | 1 | 2014 | 6 | 0.430 |
Why?
| | Nutrition Policy | 6 | 2017 | 56 | 0.430 |
Why?
| | Starch | 1 | 2015 | 22 | 0.430 |
Why?
| | Pregnancy Trimester, First | 7 | 2023 | 140 | 0.430 |
Why?
| | Labor, Obstetric | 4 | 2026 | 67 | 0.430 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2024 | 55 | 0.430 |
Why?
| | Risk Factors | 27 | 2026 | 10921 | 0.420 |
Why?
| | Calcium | 5 | 2022 | 1181 | 0.420 |
Why?
| | Brain | 2 | 2017 | 2991 | 0.420 |
Why?
| | Oryza | 2 | 2026 | 34 | 0.410 |
Why?
| | Infant, Premature, Diseases | 1 | 2015 | 113 | 0.410 |
Why?
| | Adiposity | 3 | 2018 | 533 | 0.410 |
Why?
| | Intestinal Diseases | 2 | 2026 | 43 | 0.410 |
Why?
| | Age Factors | 9 | 2015 | 3347 | 0.410 |
Why?
| | Cohort Studies | 14 | 2021 | 6077 | 0.410 |
Why?
| | Health Promotion | 4 | 2023 | 786 | 0.400 |
Why?
| | Aging | 6 | 2018 | 1996 | 0.400 |
Why?
| | Educational Status | 11 | 2022 | 466 | 0.400 |
Why?
| | Calcium, Dietary | 5 | 2022 | 52 | 0.400 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 27 | 0.390 |
Why?
| | Socioeconomic Factors | 13 | 2024 | 1327 | 0.390 |
Why?
| | Pediatrics | 6 | 2018 | 1124 | 0.390 |
Why?
| | Randomized Controlled Trials as Topic | 10 | 2026 | 1763 | 0.390 |
Why?
| | Regression Analysis | 10 | 2016 | 999 | 0.380 |
Why?
| | Income | 9 | 2023 | 206 | 0.380 |
Why?
| | Dysprosium | 2 | 2010 | 2 | 0.380 |
Why?
| | Antioxidants | 1 | 2016 | 544 | 0.370 |
Why?
| | Flour | 4 | 2015 | 6 | 0.370 |
Why?
| | Hypertension, Pregnancy-Induced | 2 | 2023 | 69 | 0.370 |
Why?
| | Occupational Health Services | 1 | 2012 | 36 | 0.360 |
Why?
| | Pregnancy Trimester, Third | 3 | 2017 | 117 | 0.360 |
Why?
| | Metagenome | 1 | 2013 | 127 | 0.360 |
Why?
| | Triticum | 2 | 2009 | 18 | 0.350 |
Why?
| | Heme | 1 | 2012 | 90 | 0.350 |
Why?
| | Glucocorticoids | 4 | 2016 | 536 | 0.350 |
Why?
| | Dietary Carbohydrates | 2 | 2010 | 146 | 0.350 |
Why?
| | Neurodevelopmental Disorders | 3 | 2023 | 239 | 0.340 |
Why?
| | Protein Hydrolysates | 2 | 2002 | 6 | 0.340 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2021 | 320 | 0.340 |
Why?
| | Caseins | 2 | 2002 | 20 | 0.340 |
Why?
| | Maternal Age | 12 | 2020 | 129 | 0.340 |
Why?
| | Social Class | 3 | 2022 | 260 | 0.340 |
Why?
| | Intestinal Mucosa | 7 | 2018 | 666 | 0.340 |
Why?
| | Iodine | 4 | 2026 | 26 | 0.340 |
Why?
| | Administration, Oral | 9 | 2026 | 872 | 0.330 |
Why?
| | Diet Records | 6 | 2026 | 87 | 0.330 |
Why?
| | Folic Acid | 5 | 2026 | 197 | 0.330 |
Why?
| | Public Health | 4 | 2025 | 574 | 0.320 |
Why?
| | Zika Virus Infection | 2 | 2025 | 174 | 0.320 |
Why?
| | Cross-Over Studies | 7 | 2026 | 615 | 0.320 |
Why?
| | Gastrointestinal Tract | 1 | 2013 | 203 | 0.310 |
Why?
| | Failure to Thrive | 3 | 2009 | 27 | 0.310 |
Why?
| | Maternal-Child Health Services | 3 | 2019 | 12 | 0.310 |
Why?
| | Wasting Syndrome | 1 | 2010 | 12 | 0.310 |
Why?
| | Workplace | 1 | 2012 | 268 | 0.310 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.310 |
Why?
| | Biological Transport | 3 | 2021 | 424 | 0.300 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2219 | 0.300 |
Why?
| | Nutritional Physiological Phenomena | 4 | 2022 | 57 | 0.300 |
Why?
| | Nutrition Surveys | 1 | 2011 | 270 | 0.300 |
Why?
| | Logistic Models | 5 | 2026 | 2126 | 0.300 |
Why?
| | Time Factors | 9 | 2021 | 7109 | 0.300 |
Why?
| | Asphyxia Neonatorum | 2 | 2026 | 20 | 0.300 |
Why?
| | Absorption | 11 | 2013 | 60 | 0.290 |
Why?
| | Quality Indicators, Health Care | 1 | 2012 | 343 | 0.280 |
Why?
| | Staining and Labeling | 1 | 2009 | 148 | 0.280 |
Why?
| | Fetus | 4 | 2021 | 800 | 0.280 |
Why?
| | Neonatal Sepsis | 2 | 2026 | 9 | 0.280 |
Why?
| | Medically Underserved Area | 3 | 2018 | 102 | 0.270 |
Why?
| | Environment | 3 | 2026 | 299 | 0.270 |
Why?
| | Salmon | 2 | 2025 | 20 | 0.270 |
Why?
| | Seafood | 2 | 2025 | 25 | 0.270 |
Why?
| | Patient Safety | 1 | 2012 | 352 | 0.270 |
Why?
| | Selenium | 2 | 2025 | 48 | 0.270 |
Why?
| | Latin America | 7 | 2026 | 96 | 0.260 |
Why?
| | Follow-Up Studies | 8 | 2026 | 5439 | 0.260 |
Why?
| | Lipids | 2 | 2024 | 714 | 0.260 |
Why?
| | Asia | 7 | 2026 | 69 | 0.260 |
Why?
| | Practice Guidelines as Topic | 4 | 2016 | 1591 | 0.260 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2023 | 1408 | 0.250 |
Why?
| | Cytokines | 3 | 2021 | 2081 | 0.250 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 307 | 0.250 |
Why?
| | Folic Acid Deficiency | 2 | 2025 | 49 | 0.240 |
Why?
| | Urinalysis | 5 | 2020 | 82 | 0.240 |
Why?
| | Adiponectin | 2 | 2018 | 243 | 0.240 |
Why?
| | Pediatric Obesity | 3 | 2023 | 635 | 0.240 |
Why?
| | Minerals | 2 | 2025 | 48 | 0.240 |
Why?
| | Dietary Sugars | 1 | 2026 | 21 | 0.240 |
Why?
| | Fast Foods | 1 | 2026 | 24 | 0.240 |
Why?
| | Sodium, Dietary | 1 | 2026 | 43 | 0.240 |
Why?
| | Communicable Diseases | 2 | 2023 | 166 | 0.230 |
Why?
| | Africa | 6 | 2026 | 119 | 0.230 |
Why?
| | Deoxyglucose | 1 | 2026 | 51 | 0.230 |
Why?
| | Health Personnel | 3 | 2023 | 754 | 0.230 |
Why?
| | Blueberry Plants | 1 | 2025 | 8 | 0.230 |
Why?
| | Postpartum Hemorrhage | 1 | 2026 | 28 | 0.230 |
Why?
| | Referral and Consultation | 3 | 2019 | 881 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.220 |
Why?
| | Cause of Death | 2 | 2018 | 456 | 0.220 |
Why?
| | Bone and Bones | 2 | 2019 | 319 | 0.220 |
Why?
| | Colorado | 7 | 2017 | 4595 | 0.220 |
Why?
| | Risk Assessment | 7 | 2018 | 3712 | 0.220 |
Why?
| | Perinatal Care | 2 | 2018 | 61 | 0.210 |
Why?
| | Vitamin B 12 | 4 | 2026 | 140 | 0.210 |
Why?
| | Schools, Medical | 1 | 2006 | 158 | 0.210 |
Why?
| | Drug Resistance, Bacterial | 1 | 2026 | 185 | 0.210 |
Why?
| | Microcephaly | 1 | 2025 | 106 | 0.210 |
Why?
| | Internship and Residency | 2 | 2019 | 1281 | 0.210 |
Why?
| | Saliva | 2 | 2026 | 256 | 0.210 |
Why?
| | Maternal Welfare | 2 | 2014 | 22 | 0.200 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.200 |
Why?
| | Parents | 1 | 2013 | 1394 | 0.200 |
Why?
| | Streptococcus pneumoniae | 1 | 2026 | 187 | 0.200 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2026 | 188 | 0.200 |
Why?
| | Feasibility Studies | 4 | 2023 | 1135 | 0.200 |
Why?
| | Climate Change | 1 | 2026 | 184 | 0.200 |
Why?
| | Retrospective Studies | 9 | 2023 | 17438 | 0.200 |
Why?
| | Reference Values | 4 | 2022 | 796 | 0.200 |
Why?
| | China | 5 | 2014 | 280 | 0.190 |
Why?
| | Ferritins | 2 | 2016 | 69 | 0.190 |
Why?
| | Milk | 3 | 2018 | 117 | 0.190 |
Why?
| | Erythrocytes | 5 | 2022 | 750 | 0.190 |
Why?
| | United States | 15 | 2026 | 16136 | 0.190 |
Why?
| | Soybean Proteins | 1 | 2002 | 15 | 0.190 |
Why?
| | Food Assistance | 1 | 2023 | 34 | 0.190 |
Why?
| | Vitamin K | 1 | 2023 | 46 | 0.190 |
Why?
| | Parenteral Nutrition | 1 | 2024 | 102 | 0.190 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2002 | 24 | 0.190 |
Why?
| | Labor Presentation | 2 | 2019 | 2 | 0.190 |
Why?
| | Vitamin A | 1 | 2023 | 60 | 0.190 |
Why?
| | Plant Oils | 1 | 2002 | 33 | 0.190 |
Why?
| | Pandemics | 4 | 2024 | 1707 | 0.180 |
Why?
| | Infant Care | 2 | 2015 | 43 | 0.180 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2023 | 104 | 0.180 |
Why?
| | Temperature | 2 | 2023 | 635 | 0.180 |
Why?
| | Faculty, Medical | 1 | 2006 | 309 | 0.180 |
Why?
| | Health Facilities | 2 | 2020 | 85 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 253 | 0.180 |
Why?
| | Drug Monitoring | 1 | 2026 | 399 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2019 | 2022 | 0.180 |
Why?
| | Puerperal Infection | 3 | 2024 | 5 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 2 | 2016 | 486 | 0.180 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2020 | 665 | 0.180 |
Why?
| | Africa South of the Sahara | 5 | 2026 | 56 | 0.180 |
Why?
| | Postnatal Care | 2 | 2020 | 76 | 0.180 |
Why?
| | Hyperglycemia | 1 | 2026 | 384 | 0.180 |
Why?
| | Adolescent Health | 2 | 2019 | 38 | 0.180 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2026 | 499 | 0.170 |
Why?
| | Zinc Oxide | 3 | 2012 | 9 | 0.170 |
Why?
| | Fatty Acids | 3 | 2022 | 460 | 0.170 |
Why?
| | Tobacco, Smokeless | 1 | 2021 | 13 | 0.170 |
Why?
| | Staphylococcus aureus | 1 | 2026 | 459 | 0.170 |
Why?
| | Enteral Nutrition | 1 | 2024 | 212 | 0.170 |
Why?
| | Midwifery | 3 | 2014 | 70 | 0.170 |
Why?
| | Bone Density | 3 | 2006 | 494 | 0.170 |
Why?
| | Rural Health | 5 | 2016 | 87 | 0.170 |
Why?
| | Students | 1 | 2007 | 649 | 0.170 |
Why?
| | Biomedical Research | 3 | 2017 | 729 | 0.170 |
Why?
| | Patient Dropouts | 2 | 2012 | 65 | 0.170 |
Why?
| | Tablets | 4 | 2022 | 41 | 0.170 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 13 | 0.170 |
Why?
| | Isoleucine | 1 | 2021 | 15 | 0.170 |
Why?
| | Respiration, Artificial | 1 | 2026 | 711 | 0.160 |
Why?
| | Selenoproteins | 1 | 2020 | 7 | 0.160 |
Why?
| | Cystic Fibrosis | 3 | 2000 | 1164 | 0.160 |
Why?
| | Birth Rate | 1 | 2020 | 32 | 0.160 |
Why?
| | Health Status | 1 | 2026 | 827 | 0.160 |
Why?
| | Animals | 17 | 2025 | 38107 | 0.160 |
Why?
| | Phenylalanine | 1 | 2021 | 69 | 0.160 |
Why?
| | Valine | 1 | 2021 | 84 | 0.160 |
Why?
| | Hyperinsulinism | 1 | 2021 | 115 | 0.160 |
Why?
| | Digestive System Physiological Phenomena | 1 | 2000 | 5 | 0.160 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 6073 | 0.160 |
Why?
| | Carnitine | 1 | 2021 | 91 | 0.160 |
Why?
| | Leucine | 1 | 2021 | 116 | 0.160 |
Why?
| | Treatment Outcome | 5 | 2018 | 11821 | 0.160 |
Why?
| | Parturition | 1 | 2021 | 72 | 0.150 |
Why?
| | Oligohydramnios | 1 | 2020 | 15 | 0.150 |
Why?
| | Linear Models | 4 | 2016 | 857 | 0.150 |
Why?
| | Biotransformation | 1 | 2020 | 61 | 0.150 |
Why?
| | Endotoxemia | 1 | 2020 | 85 | 0.150 |
Why?
| | Cleft Lip | 1 | 2020 | 73 | 0.150 |
Why?
| | Pasteurization | 1 | 2019 | 3 | 0.150 |
Why?
| | Digestion | 2 | 2017 | 17 | 0.150 |
Why?
| | Quality of Health Care | 3 | 2020 | 702 | 0.150 |
Why?
| | International Classification of Diseases | 1 | 2020 | 142 | 0.150 |
Why?
| | Spouses | 1 | 2021 | 107 | 0.150 |
Why?
| | Leukocyte L1 Antigen Complex | 2 | 2026 | 40 | 0.150 |
Why?
| | Thinness | 2 | 2018 | 100 | 0.150 |
Why?
| | Diet, Fat-Restricted | 1 | 2000 | 79 | 0.150 |
Why?
| | Liver | 6 | 2020 | 1864 | 0.150 |
Why?
| | Lactulose | 1 | 2019 | 2 | 0.150 |
Why?
| | Cleft Palate | 1 | 2020 | 91 | 0.150 |
Why?
| | Polyhydramnios | 1 | 2019 | 16 | 0.150 |
Why?
| | Calorimetry | 1 | 2019 | 69 | 0.150 |
Why?
| | Intestines | 3 | 2019 | 351 | 0.150 |
Why?
| | Mannitol | 1 | 2019 | 42 | 0.150 |
Why?
| | Health Resources | 1 | 2020 | 131 | 0.150 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 175 | 0.150 |
Why?
| | Cholesterol, HDL | 2 | 2023 | 201 | 0.150 |
Why?
| | Hepcidins | 1 | 2019 | 20 | 0.140 |
Why?
| | Endemic Diseases | 1 | 2019 | 34 | 0.140 |
Why?
| | Pilot Projects | 3 | 2023 | 1888 | 0.140 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 324 | 0.140 |
Why?
| | Hypersensitivity, Immediate | 1 | 2019 | 41 | 0.140 |
Why?
| | Malawi | 4 | 2015 | 58 | 0.140 |
Why?
| | Species Specificity | 1 | 2020 | 543 | 0.140 |
Why?
| | Beverages | 4 | 2019 | 67 | 0.140 |
Why?
| | Ghrelin | 1 | 2018 | 42 | 0.140 |
Why?
| | Adolescent Development | 1 | 2019 | 72 | 0.140 |
Why?
| | Blood Urea Nitrogen | 1 | 2018 | 53 | 0.140 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 32 | 0.140 |
Why?
| | Middle Aged | 10 | 2025 | 36619 | 0.140 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 200 | 0.140 |
Why?
| | Meat Products | 2 | 2012 | 9 | 0.140 |
Why?
| | Glucose | 3 | 2023 | 1053 | 0.140 |
Why?
| | Erythrocyte Indices | 2 | 2021 | 33 | 0.130 |
Why?
| | Oxidative Stress | 2 | 2017 | 1369 | 0.130 |
Why?
| | Exercise | 7 | 2023 | 2213 | 0.130 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 588 | 0.130 |
Why?
| | Proteobacteria | 1 | 2017 | 15 | 0.130 |
Why?
| | Bifidobacterium | 1 | 2017 | 21 | 0.130 |
Why?
| | Clostridium | 1 | 2017 | 19 | 0.130 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 455 | 0.130 |
Why?
| | Cluster Analysis | 5 | 2019 | 496 | 0.130 |
Why?
| | Indians, Central American | 1 | 2017 | 6 | 0.130 |
Why?
| | Food Supply | 1 | 2018 | 94 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2019 | 267 | 0.120 |
Why?
| | Isotopes | 1 | 2017 | 33 | 0.120 |
Why?
| | Infusions, Intravenous | 3 | 2006 | 432 | 0.120 |
Why?
| | Postoperative Complications | 2 | 2009 | 3034 | 0.120 |
Why?
| | Food Analysis | 2 | 2015 | 22 | 0.120 |
Why?
| | Head | 2 | 2010 | 125 | 0.120 |
Why?
| | Copper | 3 | 2004 | 122 | 0.120 |
Why?
| | Appetite | 2 | 2010 | 80 | 0.120 |
Why?
| | Gene Expression | 1 | 2021 | 1463 | 0.120 |
Why?
| | Professional-Family Relations | 1 | 2018 | 158 | 0.120 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.120 |
Why?
| | Communication | 1 | 2023 | 980 | 0.120 |
Why?
| | Dietary Sucrose | 1 | 2016 | 49 | 0.120 |
Why?
| | Social Determinants of Health | 1 | 2020 | 317 | 0.120 |
Why?
| | Interleukin-8 | 1 | 2017 | 268 | 0.120 |
Why?
| | Blood Pressure | 2 | 2020 | 1765 | 0.120 |
Why?
| | Biomedical Technology | 1 | 2017 | 49 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.120 |
Why?
| | Intensive Care, Neonatal | 1 | 2016 | 41 | 0.120 |
Why?
| | Down-Regulation | 1 | 2018 | 614 | 0.120 |
Why?
| | Population Surveillance | 4 | 2020 | 481 | 0.120 |
Why?
| | Spectrophotometry, Atomic | 8 | 2013 | 13 | 0.110 |
Why?
| | Pneumonia | 3 | 2009 | 635 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Ethiopia | 4 | 2009 | 43 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 145 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3416 | 0.110 |
Why?
| | Insulin Resistance | 2 | 2021 | 1247 | 0.110 |
Why?
| | Overnutrition | 1 | 2015 | 28 | 0.110 |
Why?
| | Data Accuracy | 1 | 2015 | 64 | 0.110 |
Why?
| | World Health Organization | 3 | 2012 | 104 | 0.110 |
Why?
| | Haemophilus influenzae type b | 1 | 2014 | 12 | 0.110 |
Why?
| | Diabetes Mellitus | 4 | 2016 | 1101 | 0.110 |
Why?
| | Bacterial Capsules | 1 | 2014 | 33 | 0.110 |
Why?
| | American Heart Association | 1 | 2016 | 364 | 0.110 |
Why?
| | Haemophilus Vaccines | 1 | 2014 | 29 | 0.110 |
Why?
| | Multivariate Analysis | 5 | 2020 | 1543 | 0.110 |
Why?
| | Antibody Affinity | 1 | 2014 | 60 | 0.110 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 220 | 0.110 |
Why?
| | Pregnancy in Adolescence | 1 | 2015 | 78 | 0.100 |
Why?
| | Drug Utilization | 3 | 2024 | 171 | 0.100 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 771 | 0.100 |
Why?
| | Chile | 2 | 2012 | 26 | 0.100 |
Why?
| | Contraception Behavior | 1 | 2015 | 108 | 0.100 |
Why?
| | Family Planning Services | 1 | 2015 | 93 | 0.100 |
Why?
| | Placenta | 1 | 2021 | 794 | 0.100 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 640 | 0.100 |
Why?
| | Up-Regulation | 1 | 2017 | 841 | 0.100 |
Why?
| | Stroke | 1 | 2023 | 1287 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2016 | 247 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 344 | 0.100 |
Why?
| | Food Preferences | 1 | 2015 | 126 | 0.100 |
Why?
| | Algorithms | 3 | 2017 | 1849 | 0.100 |
Why?
| | Life Style | 2 | 2015 | 496 | 0.100 |
Why?
| | Antibodies, Bacterial | 1 | 2014 | 147 | 0.100 |
Why?
| | Pennisetum | 1 | 2013 | 2 | 0.100 |
Why?
| | Hair | 3 | 2011 | 81 | 0.100 |
Why?
| | Central America | 2 | 2025 | 28 | 0.100 |
Why?
| | Acrodermatitis | 1 | 2013 | 1 | 0.100 |
Why?
| | Population Groups | 1 | 2013 | 55 | 0.100 |
Why?
| | Alkaline Phosphatase | 3 | 2011 | 144 | 0.100 |
Why?
| | Pregnancy, Multiple | 1 | 2013 | 19 | 0.100 |
Why?
| | Qualitative Research | 1 | 2021 | 1734 | 0.090 |
Why?
| | Escherichia coli | 1 | 2017 | 832 | 0.090 |
Why?
| | Indicator Dilution Techniques | 4 | 2006 | 12 | 0.090 |
Why?
| | Neonatology | 1 | 2013 | 36 | 0.090 |
Why?
| | Puerperal Disorders | 3 | 2020 | 35 | 0.090 |
Why?
| | Liver Diseases | 3 | 2013 | 304 | 0.090 |
Why?
| | Prolactin | 2 | 2007 | 88 | 0.090 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 287 | 0.090 |
Why?
| | Iron Radioisotopes | 1 | 2012 | 2 | 0.090 |
Why?
| | Needs Assessment | 2 | 2015 | 404 | 0.090 |
Why?
| | Health Services Accessibility | 2 | 2019 | 1107 | 0.090 |
Why?
| | Puerto Rico | 2 | 2025 | 64 | 0.090 |
Why?
| | Fetal Growth Retardation | 3 | 2025 | 592 | 0.090 |
Why?
| | Endocrine System | 1 | 2012 | 23 | 0.090 |
Why?
| | Poverty Areas | 1 | 2012 | 43 | 0.090 |
Why?
| | Urban Health | 1 | 2012 | 95 | 0.090 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2012 | 64 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 178 | 0.090 |
Why?
| | Triglycerides | 1 | 2014 | 527 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 71 | 0.090 |
Why?
| | Intestine, Small | 2 | 2011 | 160 | 0.090 |
Why?
| | Analysis of Variance | 3 | 2002 | 1298 | 0.090 |
Why?
| | Ferrous Compounds | 3 | 2026 | 25 | 0.080 |
Why?
| | Morphogenesis | 1 | 2012 | 163 | 0.080 |
Why?
| | Erythrocyte Membrane | 1 | 2011 | 55 | 0.080 |
Why?
| | Cerebrovascular Disorders | 1 | 2012 | 103 | 0.080 |
Why?
| | Obstetrics | 1 | 2013 | 179 | 0.080 |
Why?
| | Zika Virus | 2 | 2025 | 137 | 0.080 |
Why?
| | Chickens | 1 | 2011 | 169 | 0.080 |
Why?
| | Clinical Competence | 1 | 2019 | 1272 | 0.080 |
Why?
| | International Agencies | 1 | 2011 | 30 | 0.080 |
Why?
| | Spectrometry, Mass, Fast Atom Bombardment | 4 | 1998 | 7 | 0.080 |
Why?
| | Digestive System | 2 | 2001 | 29 | 0.080 |
Why?
| | Incidence | 4 | 2019 | 2936 | 0.080 |
Why?
| | Curriculum | 3 | 2019 | 1079 | 0.080 |
Why?
| | Single-Blind Method | 1 | 2011 | 313 | 0.080 |
Why?
| | Growth Charts | 1 | 2010 | 20 | 0.080 |
Why?
| | Inositol Phosphates | 1 | 2010 | 21 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 368 | 0.080 |
Why?
| | Interleukin-6 | 1 | 2014 | 784 | 0.080 |
Why?
| | Food, Formulated | 1 | 1989 | 16 | 0.080 |
Why?
| | Language | 1 | 2013 | 315 | 0.080 |
Why?
| | Argentina | 3 | 2014 | 28 | 0.080 |
Why?
| | Interviews as Topic | 1 | 2014 | 930 | 0.070 |
Why?
| | Physicians | 2 | 2019 | 955 | 0.070 |
Why?
| | Family Nursing | 1 | 2009 | 12 | 0.070 |
Why?
| | Manganese | 1 | 1989 | 59 | 0.070 |
Why?
| | Public Assistance | 1 | 2009 | 20 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1224 | 0.070 |
Why?
| | Child Welfare | 1 | 2012 | 229 | 0.070 |
Why?
| | Program Evaluation | 1 | 2014 | 952 | 0.070 |
Why?
| | Respiratory Hypersensitivity | 1 | 2009 | 65 | 0.070 |
Why?
| | Blood Glucose | 2 | 2021 | 2360 | 0.070 |
Why?
| | Mexico | 1 | 2009 | 233 | 0.070 |
Why?
| | Cattle | 2 | 2024 | 940 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 881 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 589 | 0.070 |
Why?
| | Celiac Disease | 1 | 2011 | 285 | 0.070 |
Why?
| | Congo | 2 | 2020 | 4 | 0.070 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 561 | 0.070 |
Why?
| | Health Planning Guidelines | 1 | 2007 | 23 | 0.070 |
Why?
| | Safety | 1 | 2010 | 347 | 0.070 |
Why?
| | Food Handling | 2 | 2025 | 33 | 0.070 |
Why?
| | Ascorbic Acid | 1 | 2009 | 183 | 0.070 |
Why?
| | Urban Population | 3 | 2018 | 497 | 0.070 |
Why?
| | Nutrition Disorders | 1 | 2007 | 21 | 0.060 |
Why?
| | Disease Management | 1 | 2012 | 651 | 0.060 |
Why?
| | Child Behavior | 1 | 2009 | 234 | 0.060 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 61 | 0.060 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1271 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2623 | 0.060 |
Why?
| | Mutation | 2 | 2013 | 4093 | 0.060 |
Why?
| | Injections, Intravenous | 3 | 2004 | 197 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1998 | 0.060 |
Why?
| | Diphosphates | 1 | 2026 | 20 | 0.060 |
Why?
| | Cognition | 2 | 2009 | 1292 | 0.060 |
Why?
| | Carrier Proteins | 2 | 2002 | 728 | 0.060 |
Why?
| | Blood Transfusion | 2 | 2026 | 394 | 0.060 |
Why?
| | Sex Factors | 2 | 2010 | 2107 | 0.060 |
Why?
| | Edetic Acid | 1 | 2026 | 47 | 0.060 |
Why?
| | Research Design | 2 | 2019 | 1143 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1022 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2009 | 450 | 0.060 |
Why?
| | Peroxidase | 1 | 2026 | 168 | 0.060 |
Why?
| | Aged | 3 | 2023 | 26432 | 0.060 |
Why?
| | South America | 1 | 2025 | 56 | 0.060 |
Why?
| | Postprandial Period | 2 | 1997 | 114 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 55 | 0.050 |
Why?
| | Problem-Based Learning | 1 | 2006 | 99 | 0.050 |
Why?
| | Sex Characteristics | 1 | 2011 | 801 | 0.050 |
Why?
| | Malaria, Falciparum | 1 | 2005 | 32 | 0.050 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2025 | 81 | 0.050 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 130 | 0.050 |
Why?
| | Energy Metabolism | 2 | 2015 | 930 | 0.050 |
Why?
| | Fruit | 1 | 2025 | 144 | 0.050 |
Why?
| | Caregivers | 1 | 2014 | 1080 | 0.050 |
Why?
| | Obstetric Labor, Premature | 2 | 2016 | 39 | 0.050 |
Why?
| | Gastroplasty | 1 | 2004 | 31 | 0.050 |
Why?
| | Schools | 1 | 2007 | 436 | 0.050 |
Why?
| | Spleen | 2 | 2020 | 503 | 0.050 |
Why?
| | Health Behavior | 2 | 2023 | 802 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2026 | 790 | 0.050 |
Why?
| | Delivery of Health Care | 2 | 2022 | 947 | 0.050 |
Why?
| | Zinc Radioisotopes | 1 | 2003 | 1 | 0.050 |
Why?
| | Home Childbirth | 2 | 2013 | 5 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 36 | 0.050 |
Why?
| | Hot Temperature | 1 | 2026 | 396 | 0.050 |
Why?
| | Palm Oil | 1 | 2002 | 3 | 0.050 |
Why?
| | Calcium Compounds | 1 | 2022 | 5 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 6034 | 0.050 |
Why?
| | Sodium Chloride | 1 | 2023 | 138 | 0.050 |
Why?
| | Oxides | 1 | 2022 | 47 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 78 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2002 | 89 | 0.040 |
Why?
| | Reference Standards | 1 | 2002 | 176 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 91 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 417 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 411 | 0.040 |
Why?
| | Community Health Services | 1 | 2023 | 229 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 731 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 215 | 0.040 |
Why?
| | Magnesium | 2 | 2001 | 155 | 0.040 |
Why?
| | Glutathione Peroxidase | 1 | 2020 | 40 | 0.040 |
Why?
| | Stress, Psychological | 1 | 2009 | 1171 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2014 | 888 | 0.040 |
Why?
| | Metallothionein | 1 | 2000 | 24 | 0.040 |
Why?
| | Orosomucoid | 1 | 2020 | 10 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 1985 | 515 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 2 | 2019 | 91 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 360 | 0.040 |
Why?
| | Vaccination | 2 | 2022 | 1449 | 0.040 |
Why?
| | Licensure | 1 | 2019 | 16 | 0.040 |
Why?
| | Nicaragua | 1 | 2019 | 7 | 0.040 |
Why?
| | Child Abuse | 1 | 2005 | 545 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2921 | 0.040 |
Why?
| | Zinc Sulfate | 2 | 2012 | 8 | 0.040 |
Why?
| | Colombia | 1 | 2019 | 41 | 0.040 |
Why?
| | Peru | 1 | 2019 | 61 | 0.040 |
Why?
| | Hepatocytes | 1 | 2020 | 224 | 0.040 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 103 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 441 | 0.040 |
Why?
| | Accreditation | 1 | 2019 | 100 | 0.040 |
Why?
| | Brazil | 1 | 2019 | 179 | 0.040 |
Why?
| | Family Relations | 1 | 2000 | 87 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 25 | 0.040 |
Why?
| | Asia, Southeastern | 1 | 2018 | 13 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 2019 | 75 | 0.040 |
Why?
| | Least-Squares Analysis | 1 | 1998 | 73 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | HIV Infections | 1 | 2014 | 3215 | 0.040 |
Why?
| | Rhinitis, Allergic | 1 | 2019 | 41 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2599 | 0.030 |
Why?
| | Eczema | 1 | 2019 | 66 | 0.030 |
Why?
| | Organ Specificity | 2 | 2014 | 307 | 0.030 |
Why?
| | Microwaves | 1 | 1998 | 29 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2019 | 284 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 89 | 0.030 |
Why?
| | Focus Groups | 1 | 2021 | 588 | 0.030 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 299 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1077 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2020 | 429 | 0.030 |
Why?
| | Hospitals, Maternity | 1 | 2017 | 4 | 0.030 |
Why?
| | Pressure | 1 | 1998 | 221 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 163 | 0.030 |
Why?
| | Food-Drug Interactions | 1 | 2017 | 11 | 0.030 |
Why?
| | Tuberculosis | 1 | 2000 | 290 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2019 | 541 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 184 | 0.030 |
Why?
| | Fermentation | 1 | 2017 | 31 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 13 | 0.030 |
Why?
| | Chromatography, Gas | 1 | 2016 | 31 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 165 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 298 | 0.030 |
Why?
| | Phosphates | 1 | 1997 | 175 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 269 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 1997 | 278 | 0.030 |
Why?
| | Computer Simulation | 1 | 2000 | 1014 | 0.030 |
Why?
| | Community Health Centers | 1 | 2016 | 59 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | Kidney | 2 | 2020 | 1498 | 0.030 |
Why?
| | Dermatitis, Atopic | 1 | 2019 | 319 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 405 | 0.030 |
Why?
| | Reproductive Behavior | 1 | 2015 | 11 | 0.030 |
Why?
| | Pancreas | 1 | 1998 | 343 | 0.030 |
Why?
| | RNA, Viral | 1 | 2019 | 693 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2019 | 689 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2113 | 0.030 |
Why?
| | Dental Caries | 1 | 2016 | 173 | 0.030 |
Why?
| | Bacteria | 1 | 2020 | 766 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1792 | 0.030 |
Why?
| | Medical History Taking | 1 | 1995 | 117 | 0.030 |
Why?
| | Absorption, Physiological | 1 | 2014 | 5 | 0.030 |
Why?
| | Students, Medical | 1 | 2019 | 383 | 0.030 |
Why?
| | Vaccines, Conjugate | 1 | 2014 | 60 | 0.030 |
Why?
| | Fetal Proteins | 1 | 1994 | 15 | 0.030 |
Why?
| | Kinetics | 3 | 2007 | 1553 | 0.030 |
Why?
| | Insulin-Like Growth Factor II | 1 | 1994 | 24 | 0.030 |
Why?
| | Serum Albumin | 3 | 1999 | 147 | 0.030 |
Why?
| | Health | 1 | 2014 | 81 | 0.030 |
Why?
| | Patient Care Planning | 1 | 2015 | 170 | 0.020 |
Why?
| | Healthcare Disparities | 1 | 2020 | 733 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2014 | 334 | 0.020 |
Why?
| | Physical Examination | 1 | 1995 | 237 | 0.020 |
Why?
| | Estradiol | 1 | 1997 | 517 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 1 | 2014 | 171 | 0.020 |
Why?
| | Amino Acids | 1 | 1997 | 515 | 0.020 |
Why?
| | Uruguay | 1 | 2013 | 2 | 0.020 |
Why?
| | Pregnancy, Twin | 1 | 2013 | 19 | 0.020 |
Why?
| | Contraception | 1 | 2015 | 170 | 0.020 |
Why?
| | Hypertension | 2 | 2016 | 1272 | 0.020 |
Why?
| | Morbidity | 1 | 2014 | 319 | 0.020 |
Why?
| | Lung | 2 | 2020 | 4122 | 0.020 |
Why?
| | Fetal Mortality | 1 | 2012 | 4 | 0.020 |
Why?
| | DNA Replication | 1 | 1994 | 248 | 0.020 |
Why?
| | Liver Transplantation | 1 | 1999 | 751 | 0.020 |
Why?
| | South Australia | 1 | 2011 | 4 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1064 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 124 | 0.020 |
Why?
| | Healthy Volunteers | 1 | 2012 | 218 | 0.020 |
Why?
| | Breath Tests | 1 | 2011 | 77 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 114 | 0.020 |
Why?
| | Sucrose | 1 | 2011 | 113 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2011 | 143 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 282 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 339 | 0.020 |
Why?
| | Risk | 1 | 2013 | 920 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 511 | 0.020 |
Why?
| | Swimming | 1 | 2009 | 54 | 0.020 |
Why?
| | Ovalbumin | 1 | 2009 | 187 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2012 | 561 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2009 | 224 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2009 | 321 | 0.020 |
Why?
| | Corticosterone | 1 | 2009 | 241 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1075 | 0.020 |
Why?
| | Protein Deficiency | 1 | 2007 | 4 | 0.020 |
Why?
| | Interleukins | 1 | 2009 | 248 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2009 | 315 | 0.020 |
Why?
| | Asthma | 1 | 2019 | 1800 | 0.020 |
Why?
| | Mice | 2 | 2018 | 18297 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2009 | 642 | 0.010 |
Why?
| | Counseling | 1 | 2010 | 406 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1244 | 0.010 |
Why?
| | Food, Genetically Modified | 1 | 2006 | 2 | 0.010 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2006 | 29 | 0.010 |
Why?
| | Plants, Genetically Modified | 1 | 2006 | 16 | 0.010 |
Why?
| | Self Efficacy | 1 | 2010 | 418 | 0.010 |
Why?
| | Biliary Atresia | 1 | 1987 | 162 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 2009 | 481 | 0.010 |
Why?
| | Sweat | 1 | 1986 | 52 | 0.010 |
Why?
| | Gallstones | 1 | 2005 | 35 | 0.010 |
Why?
| | Antimalarials | 1 | 2005 | 35 | 0.010 |
Why?
| | Chloroquine | 1 | 2005 | 54 | 0.010 |
Why?
| | Placebos | 1 | 2005 | 192 | 0.010 |
Why?
| | Isotope Labeling | 1 | 2005 | 82 | 0.010 |
Why?
| | Parental Consent | 1 | 2004 | 25 | 0.010 |
Why?
| | Mental Competency | 1 | 2004 | 28 | 0.010 |
Why?
| | Anorexia | 1 | 1984 | 16 | 0.010 |
Why?
| | Family Characteristics | 1 | 2005 | 203 | 0.010 |
Why?
| | Primary Prevention | 1 | 2005 | 222 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2005 | 266 | 0.010 |
Why?
| | Informed Consent | 1 | 2004 | 195 | 0.010 |
Why?
| | Models, Statistical | 1 | 2007 | 669 | 0.010 |
Why?
| | Gastrointestinal Transit | 1 | 2002 | 6 | 0.010 |
Why?
| | Body Fluid Compartments | 1 | 2002 | 6 | 0.010 |
Why?
| | Mass Screening | 1 | 2010 | 1307 | 0.010 |
Why?
| | Free Radicals | 1 | 2001 | 104 | 0.010 |
Why?
| | Radioactive Tracers | 1 | 2000 | 5 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 226 | 0.010 |
Why?
| | Phosphorus | 1 | 2001 | 89 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 54 | 0.010 |
Why?
| | Urine | 1 | 2000 | 63 | 0.010 |
Why?
| | Blood | 1 | 2000 | 107 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 728 | 0.010 |
Why?
| | Diabetes Complications | 1 | 2001 | 219 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 8391 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2004 | 770 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4580 | 0.010 |
Why?
| | Eating | 1 | 2000 | 386 | 0.010 |
Why?
| | Postoperative Period | 1 | 1999 | 355 | 0.010 |
Why?
| | Creatinine | 1 | 1999 | 511 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1038 | 0.010 |
Why?
| | Software | 1 | 2000 | 676 | 0.010 |
Why?
| | North America | 1 | 1995 | 300 | 0.010 |
Why?
| | Europe | 1 | 1995 | 421 | 0.010 |
Why?
| | Chronic Disease | 1 | 1999 | 1827 | 0.010 |
Why?
| | Sheep | 1 | 1994 | 870 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 1989 | 226 | 0.000 |
Why?
| | Cells, Cultured | 1 | 1994 | 4118 | 0.000 |
Why?
| | Urinary Tract Infections | 1 | 1989 | 209 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1994 | 2791 | 0.000 |
Why?
| | Surgical Wound Infection | 1 | 1989 | 349 | 0.000 |
Why?
| | Blood Proteins | 1 | 1983 | 239 | 0.000 |
Why?
|
|
Krebs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|